P 
19.43
+6.35%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$2.50bn
FY2022FY2025
Net income
$16.2m
FY2022FY2025
Free cash flow
$78.9m
FY2022FY2025
Shareholders' equity
$581.0m
FY2022FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue | $2.50bn | $1.80bn | $1.37bn | $990.5m |
| Gross profit | $1.07bn | $781.3m | $601.2m | $428.9m |
| Research and development | $46.3m | $18.0m | $14.6m | $10.8m |
| Operating income | $25.4m | $87.2m | $52.8m | $4.1m |
| Net income | $16.2m | $67.9m | $41.3m | −$3.0m |
| Diluted earnings per share | 0.09 | 0.39 | 0.23 | -0.03 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Total assets | $947.6m | $664.4m | $490.9m | — |
| Cash and short-term investments | $289.0m | $175.6m | $127.2m | — |
| Total liabilities | $366.6m | $285.1m | $177.9m | — |
| Shareholders' equity | $581.0m | $379.3m | $313.0m | — |
| Shares outstanding | 176m | 176m | 176m | 91m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Cash from operations | $99.4m | $70.3m | $41.5m | $14.2m |
| Capital spending | −$20.5m | −$20.4m | −$14.5m | −$16.2m |
| Free cash flow | $78.9m | $49.9m | $27.0m | −$2.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $876.8m | $773.7m | $723.1m | $639.7m | $598.1m | $540.4m | $515.5m | $439.4m |
| Gross profit | $384.4m | $334.8m | $310.0m | $279.3m | $256.8m | $235.8m | $216.6m | $186.6m |
| Operating income | $35.5m | $39.6m | $26.0m | −$60.2m | $30.1m | $29.4m | $23.1m | $17.7m |
| Net income | $27.5m | $29.2m | $28.7m | −$223.0m | $23.8m | $22.8m | $18.2m | $14.2m |
| Diluted earnings per share | 0.15 | 0.16 | 0.16 | -1.26 | 0.13 | 0.13 | 0.10 | 0.08 |
| Cash from operations | $14.0m | $72.0m | $8.0m | $40.0m | $2.0m | $48.0m | $1.0m | $25.0m |
| Capital spending | −$10.0m | −$9.0m | −$5.0m | −$4.0m | −$5.0m | −$5.0m | −$6.0m | −$5.0m |
| Free cash flow | $4.0m | $63.0m | $3.0m | $36.0m | −$3.0m | $43.0m | −$5.0m | $20.0m |
| Total assets | $1.07bn | $967.2m | $947.6m | $843.1m | $712.3m | $669.0m | $664.4m | — |
| Cash and short-term investments | $345.8m | $344.2m | $289.0m | $312.8m | $215.3m | $218.8m | — | — |
| Debt | $10.4m | $9.0m | $8.8m | $9.6m | $8.3m | $8.3m | — | — |
| Shareholders' equity | $645.6m | $609.7m | $581.0m | $541.4m | $425.7m | $402.1m | $379.3m | — |
Financial ratios
Data as of 30 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Gross margin | 42.9% | 43.5% | 44.0% | 43.3% |
| Operating margin | -0.0% | 5.1% | 4.1% | -0.1% |
| Net margin | 0.6% | 3.8% | 3.0% | -0.3% |
| Return on equity | 2.8% | 17.9% | 13.2% | — |
| Return on assets | 1.7% | 10.2% | 8.4% | — |
| Free cash flow yield | 4.0% | 3.1% | 1.9% | 2.0% |
| Revenue growth | 39.3% | 31.5% | 37.9% | — |
| Earnings growth | -76.1% | 64.4% | -1487.0% | — |
| Current ratio | 2.34x | 2.17x | 2.59x | — |
| Debt to equity | 0.02x | 0.02x | 0.02x | — |
| Equity ratio | 61.3% | 57.1% | 63.8% | — |
| Interest coverage | -3.44x | 931.97x | 1708.30x | -2.37x |
| R&D as a share of sales | 1.9% | 1.0% | 1.1% | 1.1% |
| Buybacks as a share of market value | -0.2% | 0.0% | -93.4% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 36.2% | — | — |
| Operating income | 83.4% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 43.2% | 43.4% | — | — |
Valuation history
At each fiscal year end
| FY2025 | |
|---|---|
| Price to earnings | 125.3 |
| Price to sales | 0.8 |
Market value over time
30 Sept 2025 to 29 Oct 2026, in USD
$2.41bn$3.06bn
Share price return
Finished calendar years
| 2025 | |
|---|---|
| Return | -26% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.